Literature DB >> 18782814

Determination of the reference range of endogenous plasma carnitines in healthy adults.

Stephanie E Reuter1, Allan M Evans, Donald H Chace, Gianfranco Fornasini.   

Abstract

BACKGROUND: l-carnitine is an endogenous substance, vital in the transport of fatty acids across the inner mitochondrial membrane for oxidation. Disturbances in carnitine homeostasis can have a significant impact on human health; therefore, it is critical to define normal endogenous concentrations for l-carnitine and its esters to facilitate the diagnosis of carnitine deficiency disorders. This study was conducted to determine the normal concentrations of a number of carnitines in healthy adults using three analytical methods. The impact of age and gender on carnitine concentrations was also examined.
METHODS: Blood samples were collected from 60 healthy subjects of both genders and various ages. Plasma samples were analysed for endogenous carnitine concentrations by radioenzymatic assay, high-performance liquid chromatography and electrospray tandem mass spectrometry.
RESULTS: Precision and accuracy of results obtained for each assay were within acceptable limits. Average endogenous concentrations obtained from the three analytical methods in this study were in the range of 38-44, 6-7 and 49-50 mumol/L for l-carnitine, acetyl-l-carnitine and total carnitine, respectively. Comparison of results between the genders indicated that males had significantly higher endogenous plasma l-carnitine and total carnitine concentrations than females. Age was found to have no impact on plasma carnitine concentrations.
CONCLUSION: These results are useful in the evaluation of biochemical or metabolic disturbances and in the diagnosis and treatment of patients with carnitine deficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18782814     DOI: 10.1258/acb.2008.008045

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  18 in total

1.  Serum metabolomic profiles suggest influence of sex and oral contraceptive use.

Authors:  Margherita Ruoppolo; Ilaria Campesi; Emanuela Scolamiero; Rita Pecce; Marianna Caterino; Sara Cherchi; Giuseppe Mercuro; Giancarlo Tonolo; Flavia Franconi
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

2.  Carnitine levels in skeletal muscle, blood, and urine in patients with primary carnitine deficiency during intermission of L-carnitine supplementation.

Authors:  J Rasmussen; J A Thomsen; J H Olesen; T M Lund; M Mohr; J Clementsen; O W Nielsen; A M Lund
Journal:  JIMD Rep       Date:  2015-02-10

3.  Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands.

Authors:  Jan Rasmussen; Olav W Nielsen; Nils Janzen; Morten Duno; Hannes Gislason; Lars Køber; Ulrike Steuerwald; Allan M Lund
Journal:  J Inherit Metab Dis       Date:  2013-05-08       Impact factor: 4.982

Review 4.  Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.

Authors:  Stephanie E Reuter; Allan M Evans
Journal:  Clin Pharmacokinet       Date:  2012-09-01       Impact factor: 6.447

5.  Abnormally low serum acylcarnitine levels in narcolepsy patients.

Authors:  Taku Miyagawa; Hiroko Miyadera; Susumu Tanaka; Minae Kawashima; Mihoko Shimada; Yutaka Honda; Katsushi Tokunaga; Makoto Honda
Journal:  Sleep       Date:  2011-03-01       Impact factor: 5.849

6.  Clinical and environmental influences on metabolic biomarkers collected for newborn screening.

Authors:  Kelli K Ryckman; Stanton L Berberich; Oleg A Shchelochkov; Daniel E Cook; Jeffrey C Murray
Journal:  Clin Biochem       Date:  2012-09-23       Impact factor: 3.281

7.  Acquired encephalopathy associated with carnitine deficiency after cefditoren pivoxil administration.

Authors:  Heyun Kim; Kon Chu; Keun-Hwa Jung; Soon-Tae Lee; Jeong-Min Kim; Sang Kun Lee
Journal:  Neurol Sci       Date:  2012-01-19       Impact factor: 3.307

8.  L-carnitine and long-chain acylcarnitines are positively correlated with ambulatory blood pressure in humans: the SABPA study.

Authors:  Catharina M C Mels; Aletta E Schutte; Elardus Erasmus; Hugo W Huisman; Rudolph Schutte; Carla M T Fourie; Ruan Kruger; Johannes M Van Rooyen; Wayne Smith; Nicolaas T Malan; Leoné Malan
Journal:  Lipids       Date:  2012-10-26       Impact factor: 1.880

9.  Discovery of sexual dimorphisms in metabolic and genetic biomarkers.

Authors:  Kirstin Mittelstrass; Janina S Ried; Zhonghao Yu; Jan Krumsiek; Christian Gieger; Cornelia Prehn; Werner Roemisch-Margl; Alexey Polonikov; Annette Peters; Fabian J Theis; Thomas Meitinger; Florian Kronenberg; Stephan Weidinger; Heinz Erich Wichmann; Karsten Suhre; Rui Wang-Sattler; Jerzy Adamski; Thomas Illig
Journal:  PLoS Genet       Date:  2011-08-11       Impact factor: 5.917

10.  Association of amino acids with common complications of prematurity.

Authors:  Kelli K Ryckman; John M Dagle; Oleg A Shchelochkov; Noah Ehinger; Stanley D Poole; Stanton L Berberich; Jeff Reese; Jeffrey C Murray
Journal:  Pediatr Res       Date:  2013-03-12       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.